Medtronic Inc. has won U.S. approval for a new generation of implantable defibrillators designed to cut back on inappropriate shocks delivered by the devices, the company said on Monday.
A defibrillator is designed to shock a dangerously irregular heartbeat back to its normal rhythm. Get the full story »
